Hot Topics in IBD
In the Pipeline
Expert highlights IBD research from recent conferences
Transcript
Editor's note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.
In the past year, there have been several conferences where some of our newer treatments are looking for new indications. So some of the IL-23 medications are looking to treat and get approval for both ulcerative colitis and Crohn's. Similarly, in the S1P category, it's looking like we're trying to get approval for both UC and Crohn's.
In this video, Florence-Damilola Odufalu, MD, assistant professor of medicine at the University of Southern California, Keck School of Medicine, discusses highlights in inflammatory bowel diseases from recent conferences.
More Hot Topics in IBD
Click Here to Manage Email Alerts